Coronary diseaseAcute coronary syndromesDAY 1

SOLACI CACI | How to recommend CABG or PCI on Left Main Trunk + multi-vessel disease: CCF experience and daily practice

solaci
solaci
613
0
Dr. Conrad SWimpfendorfer
Dr. Conrad SWimpfendorfer

Leia os artigos mais destacados do primeiro dia do Congresso SOLACI-CACI 2017.

Neste caso, consulte a apresentação do Dr. Conrad Simpfendorfer, intitulada “How to recommend CABG or PCI on Left Main Trunk + multi-vessel disease: CCF experience and daily practice”.

Simpfendorfer-Conrad

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

Previous article
SOLACI CACI 2017 | Left main trunk and Multi-Vessel Disease: Improving Decision Making with SYNTAX 2 Score
Next article
SOLACI CACI 2017 | Left main PCI in 2017: Ready to EXCEL?
solaci
solaci

More articles by this author

Drugs for the Treatment of No-Reflow During PCI

Dr. Omar Tupayachi - 0
The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Dr. Omar Tupayachi - 0
Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

Dr. Omar Tupayachi - 0
In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

Dr. Omar Tupayachi - 0
The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Acute coronary syndromes

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in...
Dr. Omar Tupayachi -
SOLACI Sessionsspot_img

Recent Articles

Drugs for the Treatment of No-Reflow During PCI

Dr. Omar Tupayachi - 0
The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

Dr. Juan Manuel Pérez - 0
The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Dr. Omar Tupayachi - 0
Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...